Main Campus: Chesterfield, MO 63017 | 
Autoimmune liver disease panel
Liver disease test panel - autoimmune
An autoimmune liver disease panel is a group of tests that is done to check for autoimmune liver disease. An autoimmune liver disease means that the body's immune system attacks the liver.
These tests include:
- Anti-liver/kidney microsomal antibodies
- Anti-mitochondrial antibodies
- Anti-nuclear antibodies
- Anti-smooth muscle antibodies
The panel may also include other tests. Often, immune protein levels in the blood are also checked.
How the Test is Performed
A blood sample is taken from a vein .
Vein
An autoimmune liver disease panel is a group of tests that is done to check for autoimmune liver disease. An autoimmune liver disease means that the...
The blood sample is sent to the lab for testing.
How to Prepare for the Test
You do not need to take special steps before this test.
How the Test will Feel
You may feel slight pain or a sting when the needle is inserted to draw blood. Afterward, there may be some throbbing.
Why the Test is Performed
Autoimmune disorders are a possible cause of liver disease. The most common of these diseases are autoimmune hepatitis and primary biliary cirrhosis.
This group of tests helps your health care provider diagnose liver disease.
Normal Results
Protein levels:
The normal range for protein levels in the blood will change with each laboratory. Please check with your health care provider for the normal ranges in your particular laboratory.
Antibodies:
Negative results on all antibodies are normal.
Note: Normal value ranges may vary slightly among different laboratories. Talk to your provider about the meaning of your specific test results.
The examples above show the common measurements for results for these tests. Some laboratories use different measurements or may test different specimens.
What Abnormal Results Mean
Blood tests for autoimmune diseases are not wholly accurate. They can have false negative results (you have the disease, but the test is negative) and false positive results (you do not have the disease, but the test is positive).
A weakly positive or low titer positive test for autoimmune disease is often not due to any disease.
A positive test on the panel may be a sign of autoimmune hepatitis or other autoimmune liver disease.
If the test is positive mostly for anti-mitochondrial antibodies, you are likely to have primary biliary cirrhosis.
If the immune proteins are high and albumin is low, you may have liver cirrhosis or chronic active hepatitis.
Risks
Slight risks from having blood drawn include:
- Excessive bleeding
-
Fainting
or feeling light-headed
Fainting
Fainting is a brief loss of consciousness due to a drop in blood flow to the brain. The episode most often lasts less than a couple of minutes and y...
Read Article Now Book Mark Article - Hematoma (blood accumulating under the skin)
- Infection (a slight risk any time the skin is broken)
References
Angulo P, Lindor KD. Primary biliary cirrhosis. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease . 9th ed. Philadelphia, PA: Elsevier Saunders; 2010:chap 89.
Czaia AJ. Autoimmune hepatitis. In: In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease . 9th ed. Philadelphia, PA: Elsevier Saunders; 2010:chap 88.
Pawlotsky JM, Mchutchinson J. Chronic viral and autoimmune hepatitis. In: Goldman L, Schafer AI, eds. Goldman's Cecil Medicine . 24th ed. Philadelphia, PA: Elsevier Saunders; 2011:chap 151.
-
Liver - illustration
The liver serves a wide variety of body functions, including detoxifying blood and producing bile that aids in digestion.
Liver
illustration
-
Ulcerative colitis
(In-Depth)
-
Scleroderma
(In-Depth)
-
Diabetes
(Alt. Medicine)
-
Anemia
(In-Depth)
-
Herbal medicine
(Alt. Medicine)
Review Date: 1/11/2015
Reviewed By: Todd Eisner, MD, Private practice specializing in Gastroenterology, and Affiliate Assistant Professor, Florida Atlantic University School of Medicine, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.
